← Leaderboards
Thomas G Bernhardt
Harvard Medical School
$19,734,051
Attributed
$21,894,014
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,894,014 · 11
By mechanism
R01$12,004,052 · 2
U19$7,875,098 · 3
R33$1,525,500 · 1
R21$461,864 · 1
R13$27,500 · 4
Top collaborators
- Suzanne L. Walker5 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Suzanne L. Walker$40,048,648
- Monica T Pupo$1,738,499
- John J Mekalanos$34,471,043
- David Z Rudner$19,646,254
- Andrew Kruse$16,257,686
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaAntibioticsCellsPathway InteractionsPeptidoglycanEscherichia ColiPharmaceutical PreparationsGeneticComplexEnzymesBiogenesisPolysaccharidesProteinsCell WallInfectionGrowthPseudomonas AeruginosaGram-Negative BacteriaAntibiotic ResistanceMutantFutureStructureCombatCell Envelope
Grant awards (40)
Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria$869,512
U19 · FY2025 · AI · contact PI
Envelope biogenesis in Escherichia coli and Pseudomonas aeruginosa$615,924
R01 · FY2025 · AI · contact PI
2024 Boston Bacterial Meeting (BBM)$5,000
R13 · FY2025 · AI · contact PI
Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria$876,838
U19 · FY2024 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$535,006
R01 · FY2024 · AI · contact PI
2024 Boston Bacterial Meeting (BBM)$5,000
R13 · FY2024 · AI · contact PI
Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria$875,998
U19 · FY2023 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$535,006
R01 · FY2023 · AI · contact PI
Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria$818,532
U19 · FY2022 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$535,006
R01 · FY2022 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$535,006
R01 · FY2021 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$535,006
R01 · FY2020 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$482,553
R01 · FY2019 · AI · contact PI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob$882,519
U19 · FY2018 · AI · contact PI
Targeting cell separation systems of gram-negative bacteria.$508,500
R33 · FY2018 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$482,553
R01 · FY2018 · AI · contact PI
2018 Boston Bacterial Meeting (2018)$5,500
R13 · FY2018 · AI · contact PI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob$888,429
U19 · FY2017 · AI · contact PI
Targeting cell separation systems of gram-negative bacteria.$508,500
R33 · FY2017 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$482,553
R01 · FY2017 · AI · contact PI
2017 Boston Bacterial Meeting (BBM)$5,000
R13 · FY2017 · AI · contact PI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob$895,104
U19 · FY2016 · AI · contact PI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$858,826
R01 · FY2016 · AI · contact PI
Targeting cell separation systems of gram-negative bacteria.$508,500
R33 · FY2016 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$447,012
R01 · FY2016 · AI · contact PI
Bacterial Meeting 2016-2021$7,000
R13 · FY2016 · AI · contact PI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob$888,658
U19 · FY2015 · AI · contact PI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$858,826
R01 · FY2015 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$447,012
R01 · FY2015 · AI · contact PI
Targeting cell separation systems of gram-negative bacteria.$230,932
R21 · FY2015 · AI · contact PI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob$879,508
U19 · FY2014 · AI · contact PI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$858,826
R01 · FY2014 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$413,398
R01 · FY2014 · AI · contact PI
Targeting cell separation systems of gram-negative bacteria.$230,932
R21 · FY2014 · AI · contact PI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$807,102
R01 · FY2013 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$388,761
R01 · FY2013 · AI · contact PI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$936,346
R01 · FY2012 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$413,749
R01 · FY2012 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$413,916
R01 · FY2011 · AI · contact PI
Peptidoglycan Biogenesis in Escherichia Coli$421,665
R01 · FY2010 · AI · contact PI